Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,187 | -54,225 | -48,235 | -10,852 | -4,226 |
| Depreciation Amortization | -119 | 857 | 915 | 914 | 522 |
| Other Working Capital | -2,568 | -831 | 57 | -1,894 | -2,698 |
| Other Operating Activity | 678 | 33,029 | 32,561 | 1,128 | 760 |
| Operating Cash Flow | $-8,196 | $-21,170 | $-14,702 | $-10,704 | $-5,642 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,289 | 32,516 | 25,384 | 29,779 | -6,090 |
| PPE Investments | N/A | -285 | -259 | -235 | N/A |
| Net Acquisitions | N/A | -3,320 | -3,320 | -10,000 | N/A |
| Investing Cash Flow | $4,289 | $28,911 | $21,805 | $19,544 | $-6,090 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 43 | 29 | 29 | N/A |
| Other Financing Activity | -85 | -267 | -267 | -168 | -168 |
| Financing Cash Flow | $-85 | $-224 | $-238 | $-139 | $-168 |
| Exchange Rate Effect | -7 | -10 | -34 | N/A | N/A |
| Beginning Cash Position | 32,154 | 24,647 | 24,647 | 24,647 | 24,647 |
| End Cash Position | 28,155 | 32,154 | 31,478 | 33,348 | 12,747 |
| Net Cash Flow | $-3,999 | $7,507 | $6,831 | $8,701 | $-11,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,196 | -21,170 | -14,702 | -10,704 | -5,642 |
| Capital Expenditure | N/A | -285 | -259 | -235 | N/A |
| Free Cash Flow | -8,196 | -21,455 | -14,961 | -10,939 | -5,642 |